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Alt for å finne det sannes mysterium, 
-det er den ekte forskers kriterium. 
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This thesis is dedicated to direct compression studies of pectin, a natural polysaccharide with 
potential as a pharmaceutical excipient due to its ability to act as a carrier for colon-specific 
drug delivery as well as for sustained drug release purposes. The main objective of this thesis 
was to study the suitability of pectin as a matrix former in tablets. The compressibility and 
compactibility of pectin powders were studied as a function of various degree of 
methoxylation (DM) grades and different particle sizes.  
 
Pectin powders with similar powder characteristics were compressed by direct compression 
on a compaction simulator and an instrumented tablet press, respectively. The results showed 
that pectin powders, irrespective of DM and particle size, were classified as class IIA 
powders, showing a low degree of particle rearrangement and a relatively low degree of 
fragmentation. The powders were relatively soft and resembled the deformation behaviour of 
pregelatinized starch, an elastically deforming material. The pectinic acids (DM  10%) were 
slightly more viscoelastic than the other pectin grades. However, in general terms, it should 
be emphasized that the DM had a limited effect on the compression behaviour (i.e. 
compressibility) although an increased DM gave slightly softer and slightly less brittle 
particles. On the contrary, the compactibility was strongly dependent on both DM and initial 
particle size. The low-methoxylated (LM) pectin (DM < 50%) and especially pectinic acids 
(DM  10%) produced mechanically strong tablets, whereas the high-methoxylated (HM) 
pectins did not produce coherent tablets. The tensile strength increased with decreasing initial 
particle size. Pectin also proved to have a high dilution potential as a binder/matrix former, as 
coherent tablets were produced even when 70% of an inert material was incorporated. To 
summarize, the results showed that pectins with DM  40% have potential as direct 













API  Active pharmaceutical ingredient 
DCPD  Dibasic calcium phosphate dihydrate 
DM  Degree of methoxylation 
DSC  Differential scanning calorimetry 
ER  Elastic recovery 
GalA  1,4-linked -D-galacturonic acid 
HG  Homogalacturonan 
HM  High-methoxylated 
HPMC  Hydroxypropyl methylcellulose 
LM  Low-methoxylated 
MCC  Microcrystalline cellulose 
PGS  Pregelatinized starch 
Ph.Eur  The European Pharmacopoeia 
PXRD  Powder X-ray diffraction 
RG-I  Rhamnogalacturonan I 
RG-II  Rhamnogalacturonan II 
RH  Relative humidity 
SEM  Scanning electron microscopy 
SRS  Strain rate sensitivity 
Sv(powder) Volume-specific surface area of powder 
Sv(tablet) Volume-specific surface area of tablet 
WoC  Work of compaction 
WoE  Work of immediate elastic recovey 
YP  Yield pressure 
YP, comp. Yield pressure during the compression phase 
YP, decomp. Yield pressure during the decompression phase 











A  Constant in the Heckel equation 
a  Constant in the Kawakita equation 
b  Constant in the Kawakita equation   
C  Degree of volume reduction 
Drel  Relative density 
d  Time plasticity 
d  Tablet diameter 
E  Porosity 
E0  Initial porosity 
e  Pressure plasticity 
F  Crushing strength 
f  Constant in the Shapiro equation 
H  Height of the compact at pressure P 
H0  Initial apparent height of the powder (P = 0) 
h  Tablet height 
hat max. pressure Tablet height at maximum pressure 
hx  Tablet height at time x 
k  Constant in the Heckel equation 
k  Constant in the Shapiro equation 
P  Compaction pressure 
p  Pressure 
pmax  Maximum pressure 
t  Normalized time 
tmax  Normalized time at maximum pressure 
V  Volume of the compact at pressure P   
V0  Initial apparent volume of the powder (P = 0) 
rel, max  Maximum relative density 
  Tensile strength 
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1 AIMS OF THE THESIS 
The overall aim of this thesis was to study the compressibility and compactibility of pectin 
powders to evaluate their suitability as direct compression excipients for tabletting.  
 
More specific aims have been: 
 To characterize the powder properties of the various pectin grades (paper I and II) 
 To explore if coherent pectin tablets can be produced by direct compression employing 
zero dwell-time (paper I) 
 To study the compressibility by different approaches involving  
o classical “in-die” Heckel analysis and elastic recovery measurements “in-die” and 
“out-of-die” (paper I) 
o the use of a classification system combined with sequential handling of the 
compression parameters (paper II) 
o a simultaneous evaluation of the variables force, time and displacement by the 3-D 
modelling technique (paper III) 
 To study the effect of DM and particle size on compressibility and compactibility of 
pectin powders (paper I and II) 
 To compare the compressibility and the compactibility of pectin powders with other 
pharmaceutical powders with well-known compression behaviour (paper I-III) 
 To challenge the 3-D model by evaluating only one tablet (e.g. one relative density) in 
order to use small amounts of materials and examine how much information can be 
obtained (paper III) 
 To examine the dilution potential of pectin as a binder/matrix former and to explore its 












2.1 General methodological considerations at the early stages in 
development of tablets produced by direct compression 
A challenge at the early stages in development of tablets is the limited amount of drug 
available. Therefore, the order and type of experiments need to be planned thoroughly in 
order to keep the powder consumption low. In general, the term powder may represent active 
pharmaceutical ingredients (API’s) and/or excipients as well as mixtures of these. From a 
formulation scientist’s point of view, the optimum goal would be to obtain as much 
information as possible from as few experiments as possible in order to reduce time and costs 
(i.e. rational tablet development). In order to achieve a high-quality product, a systematic 
approach during the development phase is essential. For developing new tablets, the powder 
is firstly characterized, secondly, the compressibility is investigated, and finally, the tablets 
are characterized in terms of the powder’s compactibility. The ultimate goal is to predict the 
final tablet properties (e.g. tensile strength, drug release properties etc.) from the powder 
and/or compression characteristics.  
 
2.1.1 Suggestions on suitable powder characterization methods 
Physical properties of a powder, such as particle size, size distribution, and shape as well as 
bulk, tapped and helium densities (the last-mentioned is also known as apparent true density 
(1)), degree of crystallinity and water content, are likely to influence the compactibility of the 
powder. Several methods are available for studying the physical properties, but as the amount 
of powder is limited in the early stages of development, no more than a few methods should 
be performed for each physical property. Firstly, non-destructive methods such as helium gas 
pycnometry, should be employed. Helium density is defined as the mass of the particles 
divided by the solid volume (2). Secondly, methods that have modest sample requirements 
(milligram quantities) should be performed. These include, for example, optical microscopy, 
scanning electron microscopy (SEM), powder X-ray diffraction (PXRD), and differential 
scanning calorimetry (DSC). The microscopy methods provide information on particle shape 
and morphology. In some cases information on particle size can be obtained by measuring 
different particle diameters, for instance, Feret’s diameter. PXRD is a useful tool in describing 
the degree of crystallinity, whereas DSC provides information on phase transitions (e.g. glass 




such as evaluation of powder flow characteristics. By determining the bulk and tapped 
volumes of a powder sample, the corresponding bulk and tapped densities can be calculated. 
The European Pharmacopoeia (Ph.Eur) 2.9.34 (method 1) (3) recommends using a 250 ml 
graduated cylinder and powder samples of 100 g and 220  44 g for the bulk and tapped 
densities, respectively. These amounts are well above the sizes of the powder samples 
available in an early phase, hence, reductions may be needed. Klevan et al. has reduced the 
amount of powder to 15 – 58 g in a graduated 50 ml cylinder (4) and even further reduced the 
amount of powder to 3.5-10.3 g in a 10 ml graduated cylinder (5). The calculated bulk and 
tapped densities can be further combined to calculate the Hausner ratio and the Carr index 
(also known as the compressibility index), both of which are measures of the powder 
flowability (6, 7). Water may be present in a powder sample either as water of crystallization 
in the powder itself, as adsorbed water or in the headspace as relative humidity (RH) (8). A 
widely used method is determination of loss on drying (Ph.Eur. 2.2.32, (9)). For hygroscopic 
materials it might also be interesting to measure the equilibrium moisture sorption by plotting 
water sorption/desorption isotherms. These can be carried out either gravimetrically or 
volumetrically. Finally, the particle size distribution of the powder should be estimated. It is 
generally accepted that in the absence of electrostatic effects, it is easiest to produce 
homogeneously mixed powders if the individual components to be mixed are of similar 
particle size, particle density and spherical shape (10). The particle size distribution of dry 
powder samples can be estimated, for instance, by laser diffraction or analytical sieving. The 
latter represents a simple and widely used method and is performed according to Ph.Eur. 
2.9.38 (11). 
 
2.1.2 Examination of the compressibility  
The compressibility of a powder is defined as its ability to deform under pressure (12). During 
powder compression in a confined space, the material is subjected to compressive forces 
resulting in a volume reduction. The volume is reduced by decreases in the intra- and 
interparticulate pore space. The compression is normally described as a sequence of processes 
involving various mechanisms as described by Alderborn (13). A short summary of these 
mechanisms is presented in Figure 2.1. At low pressures, the particles firstly undergo 
rearrangement, which results in a closer packing structure and reduced porosity. When a 
certain pressure is reached, the rearrangement will cease due to the reduced space and the 
increased interparticulate friction. The further volume reduction will then take place by 




particles or fragments (i.e. particle fragmentation), or the original particles can undergo either 
temporary (i.e. elastic deformation) or permanent (i.e. plastic deformation) changes in shape 
as the pressure is increased. The literature (13) also suggests that the smaller particles 
obtained during the fragmentation could further rearrange and at higher pressures again 
undergo deformation. Thus, one single particle may undergo this cycle of events several times 
during one compression event. The mechanisms described so far have in common that all are 
time-independent processes. However, the deformation can also be time-dependent, which 
means that the degree of deformation is related to both the applied stress and the time of 
loading. This deformation behaviour is referred to as the viscoelastic and viscous deformation 
of a material (13). 
 
Rearrangement


















Figure 2.1: Schematic illustration of the mechanisms involved during compression of powder 
particles 
 
Both fragmentation and plastic deformation are considered to be strength-producing 
compression mechanisms, whereas elastic deformation is considered to be a disruptive rather 
than bond-forming mechanism (13). Since fragmentation results in the formation of smaller 




large number of contact sites between particles at which bonds can be formed. For plastic 
deformation, the increased bonding force is usually explained as an effect of increased contact 
area at the interparticulate contact sites (13).  
 
As the pressure is increased and the powder particles in a die have undergone some of the 
mechanisms described, the particle surfaces are brought into close proximity to each other and 
the consolidation phase starts. Predominantly three bonding mechanisms are assumed to take 
place during compression of dry powders: intermolecular forces, solid bridges, and 
mechanical interlocking (13). Bonding by intermolecular forces, also known as adsorption 
bonding, is formed when two solid surfaces are brought into intimate contact and 
subsequently adsorb to each other. Solid bridges, also referred to as the diffusion theory of 
bonding, occurs when two solids are mixed at their interface and accordingly form a 
continuous solid phase. Mechanical interlocking is suggested to take place in particles that are 
atypical in shape, for instance needle-shaped or highly irregular and rough, by a strength-
increasing-mechanism involving interparticulate hooking (13). 
 
As the powder compression is a complex process and takes place in several stages, it seems 
challenging, and maybe even unrealistic, to develop one simple equation with few parameters 
covering the entire compression process. Therefore, a number of different equations exist in 
the literature (14) that are capable of covering either the initial or the final stage of the 
densification process. These equations usually have in common that they require accurate 
measurements of time-resolved force and displacement data. This is achieved by employing 
instrumented tablet presses (15, 16) or compaction simulators (5, 17-19). The collected force 
and displacement data is transformed to express, for instance, the relationship between 
applied pressure and porosity. Using different equations, different compression parameters 
can be derived. The goal is that these compression parameters could be employed in 
predicting the properties of the tablets, such as, for instance, the mechanical strength (20). 











The Heckel equation (21, 22) shown as equation 1 is one of the most frequently used 










ln          (eq. 1) 
 
In this equation E represents the porosity of the compressed powder bed at applied pressure P, 
whereas k and A are constants. Heckel first claimed that it provided information on plastic 
deformation via curve fitting in the linear region in the compression phase (21, 22). Later, 
Paronen (23) suggested that information on fast elastic deformation could be obtained by 
curve fitting in the linear region in the decompression phase. The compression parameter 
obtained is denoted as the yield pressure, YP = 1/k, (either YP, comp. or YP, decomp.) and is 
often referred to as either “apparent yield pressure” or “mean yield pressure” depending on 
whether the measurement is performed “in-die” (also denoted “at-pressure”) or “out-of-die” 
(also denoted “zero-pressure” or “ejected tablet”), respectively (24). The former is often 
preferred due to its reduced time and material consumption. Per definition YP, comp. reflects 
the total deformation ability, i.e. both plastic and elastic deformation (25), even though it 
generally seems to be accepted to let YP, comp. denote the plastic deformation only. The 
equation has some limitations in describing and quantifying what actually happens at low 
pressures displayed as an initial bending in the Heckel profile (non-linearity). Heckel (21) 
claimed that this is probably due to particle movement and rearrangement processes before 
interparticulate bonding becomes appreciable. It should be emphasized that Heckel studied 
metal powders only. As pharmaceutical powders are expected to have different properties 
compared to metal powders, Denny (26) proposed that the non-linearity is caused by 
densification by brittle fracture (i.e. fragmentation) or by the presence of agglomerates of 
primary particles. 
The Heckel profile is often used to compare compression characteristics of different materials. 
In order to compare the derived compression parameters for different materials, the 
compression is either performed to the same maximum pressures (16, 18, 27) or to the same 
maximum relative densities (rel, max) of the tablets (28, 29). Figure 2.2 shows the Heckel 
profiles of four frequently used pharmaceutical excipients with different compression 
behaviour: Microcrystalline cellulose (a) is a predominantly plastically deforming material, 




(c) is an intermediately fragmenting material, whereas dibasic calcium phosphate dihydrate 
(d) shows extensive fragmentation (18). Usually a formulation scientist aims at repeating the 
experiments in order to get a measure of the variation. However, with the aid of compaction 
simulators providing highly reproducible time-resolved force and displacement data, it is 
possible to achieve high repeatability, as shown by Haware et al. (18) who obtained almost 
identical Heckel profiles in triplicate (Figure 2.2). This shows that with highly reproducible 
time-resolved force displacement data, the same amount of information can be obtained 
independently of how many repetitions are made. Thus, reducing the number of experiments 
can be justified. This reduces the powder consumption, which again is advantageous in an 
early development phase with limited powder resources available. 
  
 
Figure 2.2: Heckel profiles in triplicate with high repeatability obtained from highly 
reproducible time-resolved force and displacement data collected on a compaction simulator 







The Kawakita equation (30) is another equation providing information on the compression 























 ,        (eq. 3) 
P is the applied pressure, and C is the degree of volume reduction (30, 31), which is 
equivalent to the engineering strain of the particle bed (32, 33), thus related to volume or bed 
height at applied pressure zero (V0, H0) and P (V, H). The slope of the linear part of the 
compression phase is represented as 1/a and by extrapolating the linear regression line, 1/ab is 
found as the intercept with the y-axis. From this procedure two compression parameters are 
derived: a and 1/b. The former is commonly interpreted as a constant representing the initial 
porosity (E0) (30, 31), which corresponds to the total degree of volume reduction for the bed 
of particles (34). The Kawakita b parameter is a constant inversely related to the yield 
strength of the particles (34), and 1/b is therefore comparable to YP, comp. from the Heckel 
analysis, providing information on plastic deformation. It is generally accepted that the 
Kawakita equation is best used for low pressures and high porosities (26). The equation is 
applicable for a limited range of materials, predominantly those that produce Heckel profiles 
with a strong curvature at low pressures. As for the Heckel analysis, an amount of powder 
sufficient to produce one tablet would be satisfactory for the Kawakita analysis, if the 
prerequisite of highly repeatability data obtained from a compaction simulator is fulfilled 














The compressibility can also be studied by other more complex compaction equations such as 
the Cooper-Eaton equation (35), the log-exp-equation (also known as the Sonnergaard 
equation) (36) and the Shapiro equation (37, 38). The linear form of the last-named is shown 
in equation 4 (37, 38):   
 
ln(E) = lnE0 – kP –fP
0.5        (eq. 4) 
 
where E is the porosity, E0 is the initial porosity, P is the applied pressure and k and f are 
constants. In a Shapiro profile the f parameter is a measure of the initial bending in the first 
region, whereas the k parameter reflects the linear part during the compression phase. 
 
Another approach in examining the compressibility is to study the energy involved during the 
compaction cycle. This can be assessed via force-displacement profiles where various work 
descriptors can be calculated from different areas under the curve. The apparent work of 
compaction (WoC) represents the apparent net work used in the formation of the compact and 
the work needed to overcome die wall friction. Another work descriptor is the work of 
immediate elastic recovery (WoE), which describes the work, or energy, recovered during the 
decompression, i.e. the work of elastic recovery during decompression (39). The elastic 
recovery may continue even after ejection from the die and is observed as an increase in the 
tablet height. 
 
The classical approach is to validate the results from one equation with results obtained via 
another equation (for instance the Heckel equation vs the Kawakita equation). As a next step, 
“out-of-die” measurements of the tablet height at different time intervals make it possible to 











         (eq. 5) 
 








Recent studies indicate that the compression parameters should be handled sequentially in 
order to draw correct conclusions on the deformation mechanisms of powders (4, 5, 32). It has 
been shown statistically that the classification of a powder should be performed according to a 
series of steps (4), as illustrated in Figure 2.3.  
 
 
Figure 2.3: Schematic illustration of a new approach with sequential handling of the 
compression parameters proposed by Nordstöm et al. (32) and Klevan et al. (4, 5) (Figure 
from Klevan et al. (4)) 
 
Firstly, the particle rearrangement should be estimated, which can be done from the ab index 
derived from the Kawakita parameters a and 1/b (30, 32, 34). Materials with a high ab index 
possess high particle rearrangement and are classified as class I materials. Class II materials 
show limited particle rearrangement and hence low ab indices. Secondly, a sub-categorization 
of powder fragmentation propensity should be made, which can be performed using the 
Shapiro f parameter (5, 37, 38). The fragmentation propensity can also be investigated via 
determination of the difference in volume-specific surface area of tablets and powders; 
Sv(tablet) –Sv(powder) (13). Materials with low fragmentation propensity and limited particle 
rearrangement are classified as class IIA materials, whereas class IIB materials are defined as 




should be identified. The yield pressure from the Heckel analysis describing the permanent 
deformation of the particles should be investigated independently of particle rearrangement 
and particle fragmentation (4). With this stepwise approach, the most important material 
properties are first determined, thus reducing the risk of misinterpretation. Since the indirect 
methods involved in determining the volume-specific surface area of powder and tablets do 
not include data from compaction simulators and as such are expected to have larger standard-
deviations, these experiments require replicates, for instance, to be performed in triplicate. 
 
Another approach for studying the compression behaviour of powders is to use the 3-D 
modelling technique introduced by Picker/Picker-Freyer (40, 41). The 3-D model is presented 















    (eq. 6) 
 














































ln ,  
tmax = normalized time at maximum pressure, pmax = maximum pressure, and ω = twisting 
angle at tmax. This model allows a simultaneous evaluation of force, time and displacement. 
Three parameters are derived from the model: d, e and . Time plasticity (d) describes the 
plastic deformation with respect to time, pressure plasticity (e) describes the relationship 
between density and pressure, while the inverse angle of torsion () is a measure of the 
materials’ elastic recovery in-die (fast elastic decompression) (40, 41). Compared to Heckel 
and Kawakita analysis, the 3-D model is able to provide more detailed information on elastic 
behaviour of the materials since viscoelastic materials can be differentiated from materials 









2.1.3 Characterization of the tablets 
A powder’s compactibility is defined as its ability to form coherent strong compacts (12), 
whereas the mechanical strength of a tablet is associated with the resistance of the solid 
specimen towards attrition and fracturing (13). The intention with the attrition-resistance 
methods, also referred to as friability tests, is to mimic the kind of forces a tablet is subjected 
to all the way from production to administration. Such tests are performed according to 
Ph.Eur 2.9.7 (42). The fracture resistance is usually determined in terms of the force required 
to fracture a specimen across its diameter. The force determined in this diametral-compression 
test is denoted as the crushing strength. In order to allow comparisons of the results, the tablet 
dimensions have to be taken into consideration. This is achieved through the tensile strength 
() according to equation 7 (43):  
 
 
          (eq. 7) 
 
 
where F is the crushing strength, d is the diameter and h is the tablet height. 
 
The tensile strength should not be mixed-up with the term “hardness”, which may be defined 
as the resistance of a solid to local permanent deformation (44). Hardness is generally 
measured with static indentation methods. In general a tablet may fracture in five different 
ways. The ideal case is when a straight crack is dividing the tablet into two semi-circular 
parts. In cases where this is not obtained, a greater variability in the crushing strength 
measurements will be observed (45). Hence, Ph.Eur 2.9.8 (46) recommends measuring the 
crushing strength of ten tablets. This is easily achieved as an in-process control during 
manufacturing of tablets, but is challenging to redeem during the development phase. If 


















Pectin is a heterogeneous complex polysaccharide present in the cell wall of all higher plants. 
Commercial pectin is mainly extracted from apple pomace and citrus peel (47, 48). The 
principal component of pectin is 1,4-linked -D-galacturonic acid (GalA) (Figure 2.4), which 
constitutes the backbone of homogalacturonan (HG), one of the three main building blocks of 
pectin (49-51). The HG molecule is linear and unbranched and is often referred to as the 
“smooth region” of the pectin structure.   
 
Figure 2.4: Schematic illustration of homogalacturonan (HG) which consists of poly--1,4 
D-galacturonic acids residues (“smooth region”) (figure from (52))   
 
Rhamnogalacturonan I (RG-I) and rhamnogalacturonan II (RG-II) represent the two other 
building blocks. Contrary to HG, RG-I is a highly branched polysaccharide. Therefore, this 
pectin region is often referred to as the “hairy” region. The backbone consists of the repeating 
disaccharide 4)--D-GalA-(1  2)--L-Rha-(1  (50, 51, 53). Some of the rhamnose 
residues in RG-I are substituted at O-4 with side chains of neutral sugars, mainly arabinose 
and galactose. The branches can be composed of a single sugar unit, or of complex polymers 
such as arabinogalactan and arabinan (49-51, 53). RG-II on the contrary, has a highly 
conserved chemical structure. In spite of its name, the structure of RG-II differs strongly from 
that of RG-I. The backbone of RG-II is composed of approximately nine 1,4-linked -D-
GalA residues. This chain has four heteropolymeric side chains of known and consistent 
composition. These side chains contain 11 different monosaccharides, among them several 






The GalA residues can be methyl esterified at C-6, and the degree of methoxylation (DM) 
represents the percentage of GalA residues that carries a methyl ester. When DM  50%, the 
pectins are classified as high-methoxylated (HM), whereas pectins with DM < 50% are 
denoted as low-methoxylated (LM) (54). The latter is further subcategorised as pectinic acids 
when DM  10%. Commercially available LM pectins are prepared by controlled  
de-esterification of HM pectins with acid in alcoholic medium. 
 
2.2.3 Pharmaceutical applications  
Pectin (55) has proven suitable as a thickening agent for stabilizing suspensions (56) and 
emulsions (57). It is frequently used for controlling drug release due to its ability to swell and 
form gels, which provide diffusion and/or erosion controlled release. The LM pectins form 
gels by addition of cross-linking agents, e.g. calcium ions, whereas the HM pectins form gels 
without addition of cross linkers (58). Pectin is also a potential excipient for colon-specific 
drug delivery due to its specific degradation by colonic enzymes (59-61). Gamma 
scintigraphic studies of pectin-based tablets (62) as well as pectin-based press-coated tablets 
(63) in humans, have shown that the tablets arrived essentially intact in the colon and were 
degraded locally by enzymes. Pectin could also be combined with other polymers as a film 
forming excipint to either protect drug substances in a core or to control drug release from the 
core (64-69). As a solid dosage form, pectin-based pellets have been produced successfully 
via the extrusion/spheronization method (70-74).     
 
2.2.4 Pectin tablets   
Little attention has been given to the tabletability of pectin, despite the fact that tablets are the 
most popular solid dosage form. Sriamornsak et al. (75) have produced pectin tablets by 
direct compression for swelling studies, but applied a prolonged dwell-time of 20 seconds. In 
a study from Kim et al. (76) on the compactibility of two grades of granular pectin (DM 30-
37% and DM 65-72%), it was concluded that pectin was hard, rigid and poorly compactible. 
However, to our knowledge there exist no systematic studies on the influence of DM of pectin 
with respect to compressibility and compactibility. Therefore, pectin should not be excluded 




studies on the compressibility and compactibility of pectin are required in order to draw 




































3 SUMMARY OF PAPERS 
3.1 Paper I 
This is the first systematic study on the DM of pectin with respect to its compression 
behaviour and suitability as a direct compression excipient. Pectin was classified as a 
predominantly elastically deforming material as elastic recovery measurements were of the 
same order of magnitude as pregelatinized starch. An initial curvature of the Heckel profile 
indicated a certain degree of fragmentation. The compression behaviour was principally 
affected by the DM and to a minor degree by the particle size. Tablets with adequate tensile 
strengths were produced successfully with zero dwell-time. Both the DM and the particle size 
affected the compactibility; a correlation relating low DM grade with increasing compact 
strength was observed, and decreased particle size resulted in increased mechanical strength. 
The HM pectins did not produce coherent compacts, despite the fact that they exhibited the 
greatest degree of plastic deformation. In general the results from this paper indicated that the 
LM pectins and pectinic acids had potential as pharmaceutical excipients for direct 
compression of tablets. 
 
3.2 Paper II 
As the results from paper 1 showed that coherent pectin tablets were obtainable, the focus in 
the next paper was to perform a thorough examination of particle fragmentation and plastic 
deformation, as these compression mechanisms often are described as facilitating 
interparticulate bond formation. Recent research has shown that in order to extract 
information about the compression mechanism from powder compression data, it is important 
to interpret the phenomena in an appropriate sequential order. Therefore, the chosen approach 
in this paper was to employ a sequential handling of the “in-die” derived compression 
parameters in order to study the effect of DM and particle size on the compactibility of pectin 
powders. According to this powder classification system all pectin powders irrespective of 
DM and particle size were classified as class IIA powders, showing low degrees of particle 
rearrangement and relatively low degrees of fragmentation. Pectin particles were found to be 
relatively soft, with a tendency towards softer particles for pectins of higher DM. The overall 
variation in fragmentation and deformation behaviour was limited for the various pectin 
grades tested. Both DM and initial particle size affected the tensile strengths of the pectin 




responsible for the variation in the mechanical strengths. The suitability of LM pectins and 
pectinic acids as potential direct compression excipients was once more confirmed, as these 
powders consisted of soft particles with high compactibility. 
 
3.3 Paper III 
In this paper rational tablet development was in focus as the 3-D modelling technique was 
challenged in a development set-up using as few tablets as possible to study the compression 
behaviour of pectin powders. Compared to the evaluations performed in paper I and II, the 3-
D model provided additional information on time plasticity and elasticity. Results from one 
compression showed that the 3-D model was able to distinguish different compression 
behaviours by separating the pectin powders into three clusters: pectinic acids (DM  10%), 
LM and HM pectins. The LM pectins exhibited the highest degrees of plastic deformation and 
fast elastic deformation, whereas the pectinic acids were found to possess a certain degree of 
fragmentation. The HM pectins were more easily deformable than the pectinic acids. When 
compacts with various maximum relative densities (rel, max) were added to the classical 
equations (Heckel and Kawakita), no additional information was provided. However, with 
this set-up the 3-D model gave more detailed information on the elasticity as the shape of the 
density profile differentiated viscoelastic (pectinic acids, DM  10%) and elastically 
deforming pectins (those with a DM  25%). In general the results from paper I, II and III 
have shown that for a first classification of tabletting materials, it is suggested to use a single 
tablet and sequential handling of Kawakita, Shapiro, Heckel and the 3-D model. If the 3-D 
model is employed alone, or if the material is found to be viscoelastic, it is recommended to 













4 EXPERIMENTAL CONSIDERATIONS 
4.1 Materials 
Table 4.1: An overview of the different pectin grades and excipients used in the study. 
Material Batch no. Composition Short name Supplier Paper 




Pectin (of apple 
pomace origin) 
DM 4% Herbstreith & 
Fox, Germany 
III 





 DM 5%  I, II, III 





 DM 10%  I, II, III 











 DM 35%  II 
Pectin DM 35%a 310707DM35, 
34.8% 
 
Pectin (from citrus 
sources) 
DM 35% Herbstreith & 
Fox, Germany 
I, II, III 





 DM 40%  I, II, III 





 DM 50%  I, II, III 










 DM 72%  II, III 
Emcompress® 905003 Dibasic calcium 
phosphate 
dihydrate 
DCPD JRS Pharma, 
Germany 
 
I, II, III 
Spherolac® 100 907012 α-lactose 
monohydrate 
α-LM Meggle Pharma, 
Germany 
I, II, III 










I, II, III 







- NMD, Norway I, II, III 
Aceton - Propanone - VWR 
International, 
Norway 
I, II, III 




4.2 Features of the compaction simulator employed in this study 
Compaction simulators are computer-controlled devices designed to mimic the exact cycle of 
any tabletting process in real time with subsequent recording of all important parameters 
during the cycle (77). The instrumented eccentric presses use sinus-functions as the 
displacement function, whereas for the studies in the current thesis a saw-tooth displacement 
profile was employed in the compaction simulator. The compaction simulator employed in 
the current study is composed of two independent modules; an electromechanical precision 
press (module 1; Figure 4.1 a-c) and a powder compression device (module 2; Figure 4.2 a-b) 





Figure 4.1: The electromechanical precision press (Schmidt Servopress 450, Schmidt 
Technology GmbH, Germany; H: 2.5 m, B: 1.1 m, and T: 1.2 m); module 1 where a shows a 
schematic illustration (Schmidt Technology GmbH, reproduced with permission), and b and c 







Module 1 (Figure 4.1 a-c) is a commercially available precision press with a control unit that 
drives module 2. Force, position and speed can be set through the number of intermediate 
stages during one compression cycle. This allows a free definition of the operating profile. It 
is possible to obtain a maximum force of 50 kN, and a maximum punch speed of 200 mm/s. 
Module 2 (Figure 4.2 a-b) is a custom-made powder compression device instrumented with 
sensors that measure time-resolved force and displacement (Figure 4.3 a-d).  
a b
 
Figure 4.2: The custom-made powder compression device; module 2 where a shows a 












Figure 4.3: Sensors on module 2: Piezoelectric press force sensor at a the upper punch 
holder and b the lower punch holder. c and d: Sealed optical linear encoders for time-
resolved displacement readings (a, b, d: Original photos from (79), c: Heidenhain GmbH).  
 
Piezoelectric press force sensors (Kistler AG, Switzerland) are mounted on the upper and 
lower punch holders (Figure 4.3 a-b). These are supplied calibrated and are therefore ready to 
be used. The time-resolved displacement data of the upper punch is measured by two sealed 
optical linear encoders (Heidenhain GmbH, Germany, Figure 4.3 c) mounted on each side of 
the module (Figure 4.3 d). These are guaranteed to have a resolution of 0.1 m and an 
accuracy of  0.2 m. Tests performed by Haware (80) have shown that the displacement 
sensors are able to measure distances less than 1 m. Both static and dynamic calibration was 
performed for the displacement sensors. The former was executed by measuring the 
displacement of blocks of known sizes, whereas the latter was performed by compressing 
both the upper and the lower punches against each other (punch-to-punch) at 10 mm/s (the 
upper punch speed employed in this study). In general the dynamic calibration gives 
information on the deformation of the punches and other machine parts (e.g. punch holders). 
The raw displacement data were corrected for both the static and dynamic calibrations. The 







































5 RESULTS AND DISCUSSION 
 
5.1 Powder characterization 
Table 5.1 summarizes the powder properties of both unsieved and sieved (90-125 μm) 
qualities of pectins with DM ranging from 5 to 60% and 5 to 72%, respectively, and reference 
materials (dibasic calcium phosphate dihydrate (DCPD), -LM (-lactose monohydrate), 
microcrystalline cellulose (MCC), and pregelatinized starch (PGS)). The pectin sample with 
DM 25% was fractionated into six different size fractions (180-250 μm, 125-180 μm, 90-125 
μm, 63-90 μm, 45-63 μm and <45 μm) (Table 5.1). In general, the basic powder properties 
were all rather similar, except for the particle size expressed as D90 of the unsieved samples, 
which was approximately 220 μm for DM 25%-DM 60% and approximately 90 μm and 125 
μm for DM 5% and DM 10%, respectively. The powder flowability was generally poor as 
illustrated by Hausner ratios above 1.35, except for some samples where it was either passable 
(Hausner ratio 1.26 – 1.34) or fair (Hausner ratio 1.19 – 1.25) (6, 7). Among the reference 
materials, DCPD and -LM exhibited fair powder flow. An effect of the particle size on the 
flowability of pectin powders was also observed; the flowability became poorer with 
decreased particle size, except for the smallest size fraction as illustrated in the fractionated 
sample. In general, the cohesive forces are expected to increase with decreasing particle size, 
thus reducing the powder flowability. In order to improve the flowability, addition of a glidant 
should be considered. Possible glidants could be colloidal silica, talc or magnesium stearate, 















Table 5.1: Powder properties of unsieved and sieved qualities of pectins and reference materials 
(mean and in parenthesis relative standard deviation (%), n=3) 





















5 53.2 86.7 1.573 (0.05) 0.48 (0.32) 0.63 (0.32) 1.32 (0.00) Batches of 
different origin 10 65.1 124.9 1.595 (0.04) 0.48 (0.32) 0.63 (0.32) 1.32 (0.00) 
25 131.6 220.1 1.540 (0.10) 0.37 (1.19) 0.53 (1.14) 1.44 (0.83) 
35 136.4 224.1 1.519 (0.07) 0.38 (0.30) 0.54 (0.30) 1.43 (0.00) 
40 135.7 223.4 1.515 (0.23) 0.37 (0.27) 0.54 (0.27) 1.47 (0.00) 
50 136.4 219.7 1.543 (0.06) 0.42 (0.27) 0.57 (0.27) 1.35 (0.00) 
Batches of same 
origin 
60 135.4 220.4 1.506 (0.04) 0.43 (0.00) 0.56 (0.00) 1.28 (0.00) 
DCPD 171.0 250.2 2.369 (0.05) 0.95 (1.58) 1.14 (0.52) 1.21 (2.07) 
α-LM 117.9 203.0 1.541 (0.03) 0.68 (3.07) 0.84 (3.11) 1.22 (2.21) 
MCC 84.5 177.3 1.558 (0.07) 0.36 (0.83) 0.47 (1.48) 1.31 (2.06) 
Reference 
materials 
PGS 81.1 138.7 1.499 (0.17) 0.64 (5.33) 0.82 (1.47) 1.28 (1.01) 
Sieved powder samples 
  Size fraction 
(μm) 
    
5 90-125 1.573 (0.05) 0.49 (2.08) 0.59 (0.67) 1.21 (1.49) 
10  1.595 (0.04) 0.51 (0.39) 0.64 (1.82) 1.26 (1.47) 
35  1.631 (0.02) 0.38 (0.31) 0.52 (1.27) 1.38 (1.57) 
Batches of 
different origin 
72  1.537 (0.03) 0.34 (1.48) 0.49 (1.48) 1.44 (0.00) 
25 90-125 1.540 (0.10) 0.35 (0.50) 0.50 (0.50) 1.43 (0.00) 
35  1.519 (0.07) 0.36 (1.05) 0.50 (0.60) 1.40 (1.63) 
40  1.515 (0.23) 0.34 (0.78) 0.49 (0.92) 1.44 (1.68) 
50  1.543 (0.06) 0.40 (0.38) 0.50 (0.38) 1.25 (0.00) 
Batches of same 
origin 
60  1.506 (0.04) 0.39 (1.76) 0.48 (0.48) 1.24 (1.42) 
25 180-250 0.37 (2.00) 0.49 (1.09) 1.30 (1.49) 
 125-180 0.37 (1.03) 0.51 (1.03) 1.39 (0.00) 
 90-125 0.35 (0.50) 0.50 (0.50) 1.43 (0.00) 
 63-90 0.31 (0.00) 0.48 (0.00) 1.56 (0.00) 












0.27 (1.33) 0.36 (1.33) 1.33 (0.00) 
ameasured for the unsieved powder samples only and values employed for the sieved samples as well 
 
 
Scanning electron micrographs (SEM) of various size fractions of DM 25% are presented in 
Figure 5.1. In general the particles were fibrous and irregular in shape (Figure 5.1). This was 
applicable for all pectin samples irrespective of DM (paper I). At higher magnification (ii), 







a 180-250 μm 
     
 
b 125-180 μm 
           
 
c 90-125 μm 













d 63-90 μm 
        
 
e 45-63 μm 
      
 
f <45 μm 
      
 
Figure 5.1: SEM micrographs of different size fractions of DM 25% at two different magnifications (i: 10.0 kV x 100, ii: 







In order to study the degree of crystallinity, a powder X-ray diffraction (PXRD) analysis was 
performed on the unsieved samples (Figure 5.2). Two reflection angles were observed; one 
between 10 and 15 2 and a weaker one between 25 and 30 2. As only marginal 
differences were observed in the PXRD patterns, a similar degree of crystallinity can be 
assumed to be present in the pectin samples with various DM. 
 
 





















Pek DM 5     .
Pek DM 10     .
Pek DM 20     .
Pek DM 35     .
Pek DM 40     .
Pek DM 50     .
Pek DM 60     .
 




The sorption isotherms of pectin grades with various DM are presented in Figure 5.3. In 
general, all pectin samples increased their water content with the relative humidity (RH). At 
32% RH the water content varied from 7 to 10%. This is of the same order of magnitude as 
reported for the two hydrophilic polysaccharides chitosan (81) and carrageenan (82), as well 
as for pregelatinized (83) and acid modified starch (84) under similar experimental 
conditions. In contrast, the water sorption of microcrystalline cellulose (MCC) at 32% RH has 
been reported to be lower; approximately 5% (82, 85). It can be hypothesized that the 
difference in water sorption of pectin and MCC is due to the different molecular structures. In 
MCC strong hydrogen bonds are suggested to hold the molecules tightly together (86). For 




create a larger distance between the polymer chains, thus making them more susceptible for 
water molecules. This hypothesis seems to be confirmed by the differences in water sorption 
related to DM; the HM pectins (DM 50% and DM 60%) showed higher water sorption 
compared to the pectinic acid (e.g. DM 5%) (Figure 5.3). To summarize, the water sorption 
may be expected to be higher in pectin compared to MCC, and the water sorption was mainly 
found to increase with increasing DM. 
 




































Figure 5.3: Sorption isotherms of various pectin grades at different relative humidites (RH) 
 
The results from the powder characterization have not pointed to any major specific 
differences in the powder characteristics among the various DM grades tested. Hence, the 









5.2 Compressibility of pectin powders 
5.2.1 Classical approach 
The different compression parameters obtained through various analyses for pectin and 
reference materials with well-known compressibility, are summarized in Table 5.2. For both 
unsieved and sieved qualities of pectin powders, the classical approach with Heckel analysis 
suggested a slight increase in plasticity with increasing DM. Hence, the particles became 
softer with increased DM. The 3-D model divided the pectin samples into three groups in the 
3-D parameter plot (Figure 5.4): the pectinic acids (DM 4%, DM 5% and DM 10%), the low-
methoxylated (LM) pectins (DM 25%, DM 35% and DM 40%), and the high-methoxylated 







































Figure 5.4: 3-D parameter plot of various pectin grades and reference materials at a 
maximum relative density (rel, max) of 0.85. The numbers represent the degree of 
methoxylation (DM) of each pectin sample, and the reference materials are referred to with 
the following abbreviations: DCPD: Dibasic calcium phosphate dihydrate, MCC: 
Microcrystalline cellulose, -LM: -lactose monohydrate, and PGS: Pregelatinized starch.  




The LM pectins were suggested to be most deformable (highest d values), whereas the 
pectinic acids could be suggested to exhibit some fragmentation propensity (slightly lower e 
values and slightly higher  values). 




Table 5.2: Compression parameters of different pectin samples and reference materials (dibasic calcium phosphate dihydrate (DCPD), -lactose 
monohydrate (-LM), microcrystalline cellulose (MCC), pregelatinized starch (PGS)) of both unsieved (n = 1) and sieved (n = 3, mean and in parenthesis 
relative standard deviation (%)) qualities 
aCorresponds to an “in-die”-porosity of 0.150±0.005 (exception: 0.159 for fraction 45-63 μm DM 25%), bCalculated by linear regression from 20-80% of the maximum compaction pressure, cn=1 except for Δd where 
n=3, dn=1 except for Δd where n=2, en=1, fn=2
















    
5 104.6 645.2 3.5146 0.0027 -0.0136     Batches of different 
origin 10 114.7 689.7 3.3443 0.0024 -0.0117     
25 81.2 471.7 4.5417 0.0034 -0.0213     
35 71.8 442.5 4.6084 0.0038 -0.0245     
40 74.0 458.7 4.7321 0.0036 -0.0262     
50 83.7 463.0 3.6397 0.0035 -0.0142     
Batches of same origin 
60 70.4 444.4 3.3539 0.0042 -0.0151     
DCPD 249.4 2188.6 0.5985 0.0013 0.0064     
α-LM 98.3 1479.7 1.4331 0.0029 0.0056     
MCC 61.7 591.7 4.9609 0.0040 -0.0242     
Reference materials 
PGS 83.6 398.4 1.9923 0.0043 -0.0093     































5 90-125 21.8 118.7 (0.18) 97.5 (0.25) 0.64 (0.19) 20.5 (0.79) 0.03 (0.97) 19.5 (10.44) 0.08 (0.59) 
10  24.2 113.6 (2.05) 91.2 (0.33) 0.64 (0.21) 21.2 (0.99) 0.03 (0.85) 22.0 (9.35) 0.07 (0.60) 
35  20.1 113.6 (1.43) 90.6 (0.43) 0.67 (0.12) 13.7 (1.12) 0.05 (1.07) 16.8 (2.83) 0.11 (0.41) 
Batches of different 
origin 
72c  21.8 99.1 (-) 81.0 (-) 0.64 (-) 13.9 (-) 0.05 (-) 11.4 (14.04) 0.11 (-) 
25 90-125 20.2 103.9 (0.64) 80.2 (0.20) 0.68 (0.03) 13.2 (1.27) 0.05 (1.28) 19.4 (13.50) 0.10 (0.57) 
35  21.4 95.0 (2.65) 72.2 (0.98) 0.70 (0.29) 13.1 (2.36) 0.05 (2.32) 17.0 (3.64) 0.08 (1.44) 
40  20.6 96.9 (1.22) 72.4 (0.21) 0.70 (0.22) 13.6 (2.38) 0.05 (2.55) 21.2 (11.94) 0.08 (1.94) 
50  20.1 102.5 (2.25) 83.2 (1.50) 0.65 (0.12) 13.6 (2.62) 0.05 (2.77) 16.9 (6.17) 0.10 (1.55) 
Batches of same origin 
60  25.0 67.0 (1.76) 56.2 (1.34) 0.62 (0.44) 10.4 (1.10) 0.06 (1.44) 12.1 (2.86) 0.13 (2.74) 
25 180-250 38.6 86.9 (1.65) 69.8 (0.30) 0.66 (0.16) 11.3 (1.66) 0.06 (1.65) 23.7 (10.46) 0.11 (0.46) 
 125-180 43.7 87.1 (2.88) 67.2 (1.23) 0.67 (0.04) 11.4 (4.49) 0.06 (4.43) 25.6 (13.02)f 0.11 (2.81) 
 90-125 45.0 90.4 (1.32) 69.9 (0.31) 0.68 (0.15) 12.0 (1.21) 0.06 (1.35) 19.4 (13.50) 0.10 (0.91) 
 63-90 41.0 88.2 (1.09) 68.2 (0.10) 0.69 (0.12) 11.4 (0.88) 0.06 (0.84) 14.3 (6.73) 0.10 (1.00) 
 45-63d 41.0 88.3 (-) 70.2 (-) 0.70 (-) 10.9 (-) 0.06 (-) 6.2 (8.05) 0.10 (-) 
One batch different size 
fractions 
 <45e 39.8 87.2 (-) 68.3 (-) 0.68 (-) 12.6 (-) 0.05 (-) 3.4 (-) 0.10 (-) 
PGS 90-125 22.2 78.6 (0.35) 79.8 (0.67) 0.49 (0.20) 23.4 (2.24) 0.02 (2.02) 7.0 (24.20) 0.08 (1.55) 
α-LM  21.9 97.1 (0.84) 97.2 (1.49) 0.48 (0.09) 14.6 (1.47) 0.03 (1.54) 52.1 (5.67) 0.10 (0.23) 
Reference materials 




Comparing the Heckel profiles of a representative pectin grade (DM 25%) with reference 
materials (Figure 5.5), showed that pectin and PGS displayed the most similar curve 
progression. This was further confirmed via 3-D modelling (Figure 5.6). 
 



















 Pectin DM 25%





Figure 5.5: Heckel profiles of unsieved powders of pectin DM 25%, microcrystalline 
cellulose (MCC, Avicel PH 102), dibasic calcium phosphate dihydrate (DCPD, 
Emcompress), -lactose monohydrate (-LM, Spherolac 100) and pregelatinized starch 
(PGS, Starch 1500) at an “in-die” porosity of 0.150  0.005 (equivalent to a maximum 

























































Figure 5.6: 3-D parameter plot of three selected unsieved pectin grades (DM 4%, DM 25% 
and DM 60%) and reference materials (dibasic calcium phosphate dihydrate (DCPD), 
microcrystalline cellulose (MCC), -lactose monohydrate (-LM), and pregelatinized starch 
(PGS)) published by Picker (28). For each pectin sample the maximum relative density (rel, 
max) intervals are given. 
*: From same origin 
 
The 3-D modelling (Figure 5.6) also revealed the pectinic acids (DM  10%) to possess 
slightly more viscoelastic behaviour compared to pectins of higher DM. As the pressure 
plasticity (e) increased with increased DM, this indicated a need of higher compaction 
pressures in order to deform pectin particles of higher DM. The fact that pectin and PGS 
showed similar compression behaviour might be due to their structural similarities, both being 
polysaccharides with a backbone of monomers (D-galacturonic acid (54, 87) and -(D)-
glucose (88), the latter being a monomer in amylose and amylopectin; the two components of 







The next step with the classical approach was to evaluate the elasticity, both “in-die” and 
“out-of-die”. Figure 5.7a and 5.7b show the axial tablet expansion at different time intervals 
of low-methoxylated (LM) pectins compared to PGS, and high-methoxylated (HM) pectins 
and PGS, respectively. 
 






























































Figure 5.7: Tablet height at different time intervals (A: Under maximum compression, B: At 
the end of the decompression phase, C: Immediately after ejection from the die, D: After 24 
hours, and E: After one week) for a the low-methoxylated pectins and pregelatinized starch 




Maximum axial tablet expansion took place during the decompression phase until the tablet 
was ejected from the die (i.e. “in-die”). Slight changes in tablet heights were observed within 
24 hours of storage, and even less expansion occurred during one week. Among the pectins, 
the pectinic acids (DM  10%) displayed the lowest axial tablet expansion. This is consistent 
with the somewhat higher yield pressure values in the decompression phase (YP, decomp.) for 
these grades of pectin (Table 5.2). Pectins with DM ranging from 25% to 40% (except DM 
35% from batches of different origin) showed higher “out-of-die” axial tablet expansion 
compared to PGS. For DM 60% the axial tablet expansion was so large that the tablets 
ruptured “in-die” (DM 60%). Pectin with DM 50% and DM 72% gave mechanically weak 
tablets such that it was possible to measure the tablet heights either immediately after ejection 
from the die or after 24 hours, but it was not possible to measure the diameters as that 
procedure ruptured the tablets. It might be speculated that the high number of methoxyl 
groups, which are larger in size than the hydroxyl groups, lead to a larger degree of steric 
hindrance, possibly resulting in less strong bonds between polymeric chains, thus promoting 
higher elastic recoveries with increased DM. Another hypothesis is that the particle surface 
becomes more hydrophobic as the DM increases, thus reducing the strength of the inter-
particular bonds formed between the particles in the tablet. The corresponding “in-die” elastic 
recovery values ranged from 8.2% to 11.7% for DM 25% - DM 60%, whereas DM 5% and 
DM 10% showed values of 5.4% and 5.7%, respectively. These values are of the same order 
of magnitude as those reported for carrageenan; 8.3% (82). In another study on carrageenan 
the elastic recovery was reported to be approximately 30% after 10 days storage (89). This is 
somewhat higher than the elastic recovery values obtained for pectin (paper I, Table II), and 














5.2.2 Sequential approach 
Following the sequential handling of the compression parameters, introduced by Nordström et 
al. (32) and Klevan et al. (4, 5), pectin powders were classified as class IIA powders, showing 
a low degree of particle rearrangement (low ab indices, Table 5.2) and a relatively low degree 
of fragmentation. The latter was firstly evaluated via “in-die” Shapiro analysis of the initial 
part of the Heckel profile (Figure 5.8). 
 
























Figure 5.8: Heckel profiles (compression phase) of some pectin grades of size fraction  
90-125 m. *: From same origin. The dotted vertical lines show region I; 0-25 MPa 
 
However, this method did not succeed in estimating the degree of bending in the initial phase 
of the Heckel profiles (Figure 5.8), as visual observations did not coincide with the calculated  
f parameters (Table 5.2). This was most probably caused by higher tabletting speed and the 
way the initial powder bed height was determined in the current studies compared to the 
original method. Therefore, another method involving estimation of the difference in volume-
specific surface area of tablets and powders (Sv(tablet) – Sv(powder)) was added in order to 



































Figure 5.9: Volume-specific surface areas (Sv) of powders (white bars) and tablets (shaded 
bars) for different pectin grades of size fraction 90-125 m. *: From same origin. Standard 
deviations are presented by error bars, n = 3 
 
In general, an increased DM gave slightly less brittle particles (Figure 5.9) and somewhat 
softer particles (YP for sieved powder samples, Table 5.2). This was to some extent revealed 
during the classical approach with Heckel analysis and the 3-D modelling already discussed. 
It seems that the change in molecular structure caused by the methoxy substitution has a small 
effect on the mechanical properties of pectin particles. This is probably related to the 
interaction between the polymer chains forming the amorphous solid, and an increased DM 
will reduce the bonding (larger spatial arrangement and less hydrogen bonds) and thus 
facilitate relative motion of the polymer chains of the solid while subjected to an applied 
stress. This increased propensity to respond to an applied stress by deformation (flow), will 
reduce the tendency of the particles to fragment. However, in general terms, it should be 





5.2.3 Overall discussion 
The results have shown that pectin was predominantly deformed by elastic deformation to a 
similar extent as modified starch for direct compression. However, the pectinic acids (DM  
10%) seemed to undergo a more time-dependent deformation, i.e. viscoelastic deformation in 
combination with a slight fragmentation propensity. The results also suggested that the 
particles became softer with increased DM. According to the study performed by Kim et al. 
(76) on one LM pectin (DM 30-37%) and one HM pectin (DM 65-72%), pectin was 
suggested to consolidate predominantly by fragmentation with little plastic deformation. 
These conclusions were drawn as similar YP values (200 MPa and 213 MPa) were obtained at 
two different punch speeds: 50 mm/s and 250 mm/s, respectively. This was further supported 
by a low strain rate sensitivity value (SRS = 6.1%) for the HM pectin. The compacts also 
underwent a substantial elastic recovery during decompression and ejection. For the present 
studies a rather low punch speed of 10 mm/s was employed for compression of pectin (paper 
I-III). At higher punch speeds, plastically deforming materials such as MCC have been 
reported to decrease their apparent density and increase their fragmentation propensity, 
whereas fragmenting materials such as -LM seem unaffected (90-92). As fragmentation and 
elastic deformation seem to dominate over plastic deformation in pectin, it may be assumed 
that these compaction mechanisms will still dominate also at higher punch speeds. In general, 
tabletting troubles such as loss of hardness, sticking, lamination and capping can occur as the 
punch speed is increased (92). As the tablet tensile strength has been reported to only affect 
plastically deforming materials at higher punch speeds (93, 94), the tablet tensile strength of 
pectin may be assumed to not be affected by the punch speed to a large extent.   
As few studies exist on the compressibility of pectin powders, it is interesting to compare 
pectin’s compression behaviour with that of other natural polysaccharides. Alginates are a 
natural polysaccharide extracted from brown seaweed. They exist either as alginic acid or as 
salts of algenic acid. The polysaccharide is composed of D-mannuronic and L-guluronic acid 
(95). Alginate’s compression behaviour seems to resemble that of pectin, as it predominantly 
consolidates by elastic deformation (96). The LM pectins seem to display similar viscoelastic 
deformation behaviour as carrageenan (89), a natural polysaccharide extracted from algae of 
the class Rhodophyceae. They consist of sulfate esters of galactose and 3,6-anhydrogalactose 
copolymers, linked via -(1,3) and -(1,4) in the polymer (82). Another polysaccharide is 
chitin, which is composed of -(1,4) linked N-acetyl-D-glucosamine units (97). Its 




are waste products from the food industry (98, 99). Chitosan seems to differ from pectin by 
exhibiting a more pronounced plastic deformation (81, 97). However, a high elastic recovery 
is reported for chitosan compacts after ejection from the die (81, 97), as is also seen for pectin 
compacts (paper I). Chitosans are reported to be more plastic and elastic than DCPD (97), an 
extensively fragmenting material, and less plastic and more elastic than MCC (81, 97), known 
as an outstanding binder due to its plastic deformation. Compared to MCC, pectin was less 
plastically deforming, as the elastic component was most prominent.  
However, studies on another cellulose derivative, hydroxypropyl methylcellulose (HPMC), 
have shown relatively high elastic recovery values (27) comparable to pectin (paper I). HPMC 



























5.2.4 Effect of particle size on the compressibility of pectin powders 
Pectin DM 25% was chosen as a most typical and representative pectin grade and fractionated 
into six different size fractions. The compressibility was evaluated with the approach 
introduced by Nordström et al. (32) and Klevan et al. (4, 5). No differences were observed 
with respect to initial particle size and the ab index (Table 5.2) for the size fractions. Heckel 
profiles for the different size fractions are shown in Figure 5.10. 
 

























Figure 5.10: Heckel profiles (compression phase) of six different particle size fractions of 
pectin DM 25%. The dotted vertical lines show region I; 0-25 MPa 
 
Visual inspection revealed no differences in the initial bending, and constant f parameter 









The difference Sv(tablet) – Sv(powder), which also describes the fragmentation propensity, 
increased with decreasing initial particle size (Figure 5.11).  
 





























Figure 5.11: Volume-specific surface areas (Sv) of powders (white bars) and tablets (shaded 
bars) for six different particle size fractions of pectin DM 25%. Standard deviations are 
presented by error bars (n = 3, except for size fraction <45 m where n = 1) 
 
This is consistent with reported results for materials that undergo deformation (5, 100), and 
also shows that a large powder surface area corresponds to a larger increase in surface area 
during compression. Compared to changes in surface area of extensively fragmenting 
materials (5, 100), the Sv(tablet) – Sv(powder) for pectins were rather small, which are indicative of 
particles of relatively low fragmentation propensity. No differences in softness were observed 
for the different particle size fractions (YP and 1/b, Table 5.2). Therefore, it can be concluded 
that the compressibility of pectin powders seems to be independent of the particle size in the 






5.3 Resulting pectin tablets 
The tensile strengths of the various pectin tablets with “in-die” porosities of 0.15 are 
summarized in Figure 5.12. In general, tablets possessing adequate tensile strengths were only 
obtained from pectin grades with DM  40%, i.e. LM pectins (Figure 5.12a and Figure 5.12b). 
Hence, the HM pectins (DM  50%) did not form coherent tablets. Among the LM pectins, 
the pectinic acids (DM  10%) displayed the mechanically strongest tablets. These results 
suggest that DM influenced the tensile strength. It can be hypothesized that the particle 
surfaces become more hydrophobic as the DM increases, thus reducing the strength of the 
inter-particulate bonds formed between the particles in the tablet. DM seemed to dominate 
over other parameters that are assumed to influence the tensile strength (e.g. compaction 
pressure required to obtain an “in-die” porosity of 0.15, Table 5.2). Only minor differences in 
tablet tensile strengths were observed between tablets of unsieved (Figure 5.12a) and sieved 
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Figure 5.12: Tensile strengths of pectin tablets made from a unsieved pectin powders with 
different degrees of methoxylation (DM) (n = 1), b pectin powders with different DM and 
constant particle size (90-125 m) (n = 3), and c six different particle size fractions of pectin 
DM 25% (n = 3, except for the size fractions <45 m and 45-63 m where n = 1). *: From 





Compared to MCC, which is known to be one of the most compressible and compactible 
direct compression excipients (101), pectins with the best compactibilities (DM 5% and DM 
10%) are only capable of obtaining approximately 1/3 of MCC’s tensile strength (paper I). 
Despite this, the LM pectins seem to be suitable direct compression excipients, as the tensile 
strength values are comparable to DCPD and -LM, two materials with different 
fragmentation propensity, and higher than PGS (an elastically deforming material, paper I). 
The pectinic acids (DM  10%) seem especially promising as tablet excipients whose tensile 
strengths are comparable to carrageenan and alginate, two materials that have proven suitable 
as tablet excipients (82, 89, 96). HPMC has been reported to produce slightly stronger 
compacts than the pectinic acids; approximately 2-3 MPa for various HPMC grades at a 
compaction pressure of 100 MPa (27). Even stronger compacts can be expected for chitosan 
(81), which has shown tensile strengths of the same order of magnitude as MCC (paper I) 
approximately 6 MPa at a compaction pressure of 100 MPa. 
For pectin with DM 25%, a decreased initial particle size increased the powder 
compactibility, and thus increased the mechanical strength of the tablets (Figure 5.12c). A 
possible explanation is that the number of inter-particulate contact sites per cross sectional 
area of tablet increased with a decreased particle size. 
To summarize, it can be concluded that the mechanical strength of pectin tablets is strongly 
dependent on both DM and initial particle size. 
 
5.4 Can pectin incorporate an inert component in a matrix? 
Since the results have shown that the pectinic acids (DM  10%) are suitable as direct 
compression excipients in tabletting, they should be further examined with respect to their 
possible use as functional matrix. Therefore, DM 4% was chosen in the next study. In order 
for pectin to be successful as a binder/matrix former, its drug-loading capacity (or dilution 
potential) should be characterized. This was studied by including an inert (i.e. non-
compressible) component like quartz sand (Millisil W12) in the matrix. The following pectin 
and quartz sand mixtures (pectin:quartz sand) were compressed on an instrumented excenter 
press (the same experimental set-up as in paper III): 100:0, 70:30, 50:50, and 30:70. The 
corresponding maximum relative density (rel, max) intervals were: 0.77-0.90, 0.79-0.89, 0.77-
0.88, and 0.78-0.80, respectively. For comparison purposes, one specific rel, max of 0.83 was 




30:70 was an exception as the highest rel, max was 0.80. The tensile strengths of pectin/quartz 
tablets in different ratios are presented in Figure 5.13.  
 


























Figure 5.13: Tensile strengths of tablets made from different ratios of pectin DM 4% and 
quartz sand. Maximum relative density (rel, max): 0.83 (exception: rel, max = 0.80 for 30:70),  
n = 1 
 
Firstly, the results showed that pectin was able to produce coherent tablets, though weak, even 
when only 30% pectin was present in the matrix. This implies that pectin had a high dilution 
potential as a binder/matrix former, i.e. the drug-loading capacity was high. It should be 
emphasized that the tensile strength is low, but still coherent tablets resulted. Secondly, there 
seems to be a general trend of decreasing tensile strengths with decreasing amounts of pectin 
powder (exception: 70:30). The tensile strengths of pure pectin tablets were lower compared 
to the tensile strengths of tablets produced from pectinic acid (DM  10%) on the compaction 
simulator (Figure 5.12). This is probably caused by a combination of different tabletting 





In order to study the tablets produced from the powder mixture 70:30 in more detail, the 
tensile strengths at various rel, max were determined (Figure 5.14).  
 































Figure 5.14: Tensile strengths of tablets made from different ratios of pectin DM 4% and 
quartz sand at different maximum relative densities (rel, max), n = 1 
 
In general, the tensile strengths increased with increased values of rel, max, as expected, and no 
plateau or decrease occurred which would indicate elastic deformation. However, it should be 
kept in mind that the tensile strength was calculated for one tablet only, which may explain 
the somewhat different curve progression for tablets from the ratio 70:30. At rel, max between 
0.81 and 0.88, these tablets possessed higher tensile strengths than pure pectin tablets, and at 
similar rel, max, tablets with different tensile strengths were produced. This shows that the 
calculated tensile strengths (Figure 5.13 and Figure 5.14) for the different tablets should be 
considered to represent trends rather than accurate values. In order to calculate accurate 
tensile strength values, the crushing strength should be measured for several tablets, while 




 An “in-die” Heckel analysis was performed to measure how the plastic properties changed by 
addition of quartz sand in the matrix. The YP for the different tablet formulations is shown in 
Figure 5.15. 
 



















Figure 5.15: Yield pressure values at different ratios of pectin DM 4% and quartz sand, n = 1   
 
In general, low YP values indicate high degree of plastic deformation and vice versa. Hence, 
the plasticity gradually increased by decreased levels of quartz sand, as expected. As 
plastically deforming particles in general are expected to form strong coherent tablets, this is 










In order to get more information on the compressibility of pectin/quartz sand, the 3-D model 











































Figure 5.16: 3-D parameter plot of different ratios of pectin DM 4% and quartz sand. For 
each combination of pectin DM 4% and quartz sand the maximum relative density (rel, max) 
intervals are given 
 
The time plasticity (d) increased with increased levels of pectin in the powder. Hence, pure 
pectin powder was faster deforming than powder mixtures with pectin and increased levels of 
quartz sand. In addition, the pressure plasticity (e) increased with increasing amounts of 
pectin. This suggests the pure pectin powder to be more easily deforming at low pressures 
compared to the powder mixtures of pectin and quartz sand. This was as expected as higher 
pressures are required to compress a powder mixture containing a non-compressible 
component. These results confirm the results from the Heckel analysis (Figure 5.15). In 
addition, the 3-D modelling technique is able to provide information on the elastic properties 
of a material. The largest decrease in  values was observed for pure pectin powder, 
subsequently followed by powder mixtures with decreased levels of quartz sand. This 




amount of quartz sand increased, i.e. the properties of the rigid quartz particles became more 
prominent as the level of quartz increased. 
 
For validation purposes, the elasticity was also evaluated by measuring the axial tablet 
expansion, both “in-die” and “out-of-die”. The measured tablet heights are presented in 
Figure 5.17.  
 



































Figure 5.17: Tablet height at different time intervals (A: Under maximum compression, B: At 
the end of the decompression phase, C: Immediately after ejection from the die, D: After 24 
hours, and E: After one week) for different ratios of pectin DM 4% and quartz sand 
 
Several results are observed: Firstly, the axial tablet expansion (i.e. the elasticity) decreased 
with increased levels of quartz sand. This confirmed the results from the 3-model (Figure 
5.16). Secondly, the largest axial tablet expansion took place during the ejection from the die 
(B-C). “In-die” from when the maximum pressure was obtained until the end of 
decompression was reached (A-B), the axial tablet expansion was at the same level for the 




were observed. It is thus concluded that the elasticity was most prominent “in-die”, and 
increased with increased levels of pectin. 
 
To summarize, pectin has shown to have a high drug-loading capacity and the tablet tensile 
strength decreased with decreased amounts of pectin, even though the crushing strength 
should be tested on more than one tablet in order to calculate accurate tensile strength values. 
Both the Heckel analysis and the 3-D model showed that the plasticity increased with 
decreased levels of quartz sand. In addition, the 3-D model confirmed that the elasticity was 






























The present work shows that the low-methoxylated (LM) pectins, i.e. pectins with degrees of 
methoxylation (DM) < 50%, and especially the pectinic acids (i.e. DM  10%) are potential 
direct compression excipients consisting of soft particles with high compactibility. The 
pectinic acids produced coherent tablets with higher tensile strengths than pregelatinized 
starch (PGS) and -lactose monohydrate (-LM).  
The powder characterization revealed no major differences in powder properties among the 
various pectin grades. This implies that differences in compression behaviour cannot be 
expected to be dependent on the powder characteristics. 
Characterization of the compressibility by the classical approach employing “in-die” Heckel 
analysis followed by elastic recovery measurements both “in-die” and “out-of-die” showed 
that the pectin was elastically deforming and resembled PGS in terms of similar Heckel 
profiles. Following the sequential handling of the compression parameters, the pectin powders 
were classified as class IIA powders. Hence, the pectin powders could be expected to exhibit 
low particle rearrangement and relatively low fragmentation propensity. In general, the pectin 
particles were relatively soft. Neither DM nor initial particle size had a major effect on the 
compressibility of pectin powders, although an increased DM gave slightly softer and slightly 
less brittle particles. With the 3-D model, the pectinic acids were found to be slightly more 
viscoelastically deforming compared to the other pectin grades, which consolidated 
predominantly by elastic deformation. The latter was consistent with the results obtained via 
the classical Heckel approach and the newer approach including sequential handling of the 
compression parameters. Employing one tablet in the 3-D model set-up gave a certain degree 
of information on the compression behaviour of the pectins. However, in order to take full 
advantage of the 3-D model and to be able to differentiate elastic and viscoelastic 
deformation, addition of tablets with various maximum relative densities was necessary as the 
shape of the density profile gave this extra information.  
The LM pectins also proved to have a high dilution potential, as coherent tablets were 
produced when 70% pectin was replaced by quartz sand, an inert material. As expected, the 
plasticity of the particles in the powder blend decreased with increased amount of the quartz 
sand. Likewise, the elastic recovery decreased with increased amount of the inert material.  
Characterization of the compactibility revealed that the tensile strength was strongly 
dependent on both the DM and the initial particle size. The tensile strength increased with 




DM on powder compactibility was related to a change in surface hydrophobicity of the pectin 
particles, rather than to particle compression properties. The studies showed that coherent 
pectin tablets were successfully produced for DM  40% by direct compression employing 
zero dwell-time, whereas the high-methoxylated (HM) pectins (DM  50%) did not produce 
coherent tablets. The HM pectins are therefore not suitable as direct compression excipients. 
However, the poor flowability of pectins in general and the fact that the present study used a 
rather low upper punch speed (10 mm/s), are factors that should be further investigated in 
order to optimize pectin as a direct compression excipient. In general, it can be concluded that 
pectin represents an excipient whose compactibility could be modulated by changing the DM 
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